Pyry
Dillemuth
Doctoral Researcher, Turku PET Centre
Doctoral Researcher, Department of Chemistry
Contact
Publications
Rapid cleavage of 6-[18F]fluoronicotinic acid prosthetic group governs BT12 glioblastoma xenograft uptake: implications for radiolabeling design of biomolecules (2025)
EJNMMI Radiopharmacy and Chemistry
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Comparing Two Folate Receptor β-Targeted Tracers in a Rat Model of Experimental Autoimmune Myocarditis (2025)
ACS pharmacology & translational science
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Utilizing Monocarboxylate Transporter 1-Mediated Blood–Brain Barrier Penetration for Glioblastoma Positron Emission Tomography Imaging with 6-[18F]Fluoronicotinic Acid (2025)
Molecular Pharmaceutics
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Switching the Chemoselectivity in the Preparation of [18F]FNA-N-CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3 (2024)
Molecular Pharmaceutics
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Radiosynthesis, structural identification and in vitro tissue binding study of [18F]FNA-S-ACooP, a novel radiopeptide for targeted PET imaging of fatty acid binding protein 3 (2024)
EJNMMI Radiopharmacy and Chemistry
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Radiosynthesis, structural identifcation and in vitro tissue binding study of [18F]FNA‑S‑ACooP, a novel radiopeptide for targeted PET imaging of fatty acid binding protein 3 (2024)
EJNMMI Radiopharmacy and Chemistry
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Targeting mammary-derived growth inhibitor for positron emission tomography imaging of breast cancer brain metastasis (2023)
Nuclear Medicine and Biology
(O2 Muu julkaisu )
Comparing Folate Receptor β Targeting Tracers in Experimental Myocarditis Model (2022)
Annual Congress of European Association of Nuclear Medicine and Molecular Imaging, European Journal of Nuclear Medicine and Molecular Imaging
(Vertaisarvioimaton konferenssijulkaisu (B3))